Structural Exploration of (3S,6S)‐6‐Benzhydryl‐N‐benzyltetrahydro‐2H‐pyran‐3‐amine Analogues: Identification of Potent Triple Monoamine Reuptake Inhibitors as Potential Antidepressants

Norepinephrine transporter Reuptake Biogenic amine
DOI: 10.1002/cmdc.201200352 Publication Date: 2012-10-11T15:58:38Z
ABSTRACT
Abstract To further explore the basic structural motifs (3 S ,6 )‐6‐benzhydryl‐ N ‐benzyltetrahydro‐2 H ‐pyran‐3‐amine and (2 ,4 R ,5 )‐2‐benzhydryl‐5‐(benzylamino)tetrahydro‐2 ‐pyran‐4‐ol, developed by our research group, for monoamine transport inhibition, we designed synthesized various structurally altered analogues. The new compounds were tested their affinities dopamine transporter (DAT), serotonin (SERT), norepinephrine (NET) in rat brain measuring capacity to inhibit uptake of [ 3 H]DA, H]5‐HT, H]NE, respectively. Our results point novel with a TUI, DNRI, SNRI, or SSRI profile. Among TUIs, compound 2 g exhibited balanced potency all three transporters ( K i : 60, 79, 70.3 n M DAT, SERT, NET, respectively). In forced swim test, produced significant decrease immobility drug‐treated rats relative vehicle, indicating potential antidepressant property.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (9)